Foghorn Therapeutics (FHTX) Non-Current Assets (2020 - 2025)
Historic Non-Current Assets for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $20.8 million.
- Foghorn Therapeutics' Non-Current Assets fell 4387.15% to $20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.9 million, marking a year-over-year decrease of 3292.14%. This contributed to the annual value of $34.4 million for FY2024, which is 2482.56% down from last year.
- Per Foghorn Therapeutics' latest filing, its Non-Current Assets stood at $20.8 million for Q3 2025, which was down 4387.15% from $22.4 million recorded in Q2 2025.
- Foghorn Therapeutics' 5-year Non-Current Assets high stood at $64.6 million for Q1 2021, and its period low was $20.8 million during Q3 2025.
- Moreover, its 5-year median value for Non-Current Assets was $49.1 million (2023), whereas its average is $47.4 million.
- In the last 5 years, Foghorn Therapeutics' Non-Current Assets crashed by 394.04% in 2021 and then tumbled by 4387.15% in 2025.
- Quarter analysis of 5 years shows Foghorn Therapeutics' Non-Current Assets stood at $60.2 million in 2021, then dropped by 11.17% to $53.5 million in 2022, then decreased by 14.49% to $45.7 million in 2023, then fell by 24.83% to $34.4 million in 2024, then tumbled by 39.37% to $20.8 million in 2025.
- Its last three reported values are $20.8 million in Q3 2025, $22.4 million for Q2 2025, and $33.3 million during Q1 2025.